Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on SAM. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel epoxy ethyl methanol route for Lacosamide. High purity, scalable process. Reliable pharmaceutical intermediates supplier for global supply chains.
Patent CN105734089A reveals enzymatic synthesis for pharmaceutical intermediates. Offers high optical purity and scalable production for global supply chains.
Patent CN108660122A details high-efficiency transaminase mutant for L-glufosinate-ammonium production offering significant supply chain and cost advantages for global agrochemical manufacturers.
Patent CN111411095B discloses a novel recombinant (R)-ω-transaminase mutant with high activity and stereoselectivity for efficient sitagliptin intermediate production, ensuring supply chain stability.
Patent CN112094856B discloses high-efficiency transaminase mutants for sitagliptin synthesis, achieving >99.95% e.e. and enabling significant cost reduction in API manufacturing.
Novel chemo-enzymatic route for diabetes drug intermediate offers high purity and scalable manufacturing solutions for global pharmaceutical supply chains efficiently.
Patent CN110129306A details immobilized transaminase for besifloxacin intermediates. Offers high purity, reusability, and scalable manufacturing solutions for global pharmaceutical supply chains.
Patent CN108893455A details a transaminase mutant for L-glufosinate-ammonium production. Achieves 98% yield and 99% ee. Ideal for agrochemical intermediate supply chains seeking cost reduction.
Novel hydrophilic surfactants derived from renewable chitin. Improved solubility and surface tension control for pharma and cosmetic applications via patented synthesis.
Patent CN104894148A details a high-efficiency omega-transaminase mutant for chiral amine synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN107686852B reveals a novel omega-transaminase route for moxifloxacin intermediates, offering high ee values and streamlined manufacturing for reliable pharmaceutical intermediate suppliers.
Patent CN109503681B reveals a novel asymmetric synthesis for 2-Fluoro-L-ristosamine. Discover cost-effective manufacturing and reliable supply chain solutions for this critical pharmaceutical intermediate.
Novel enzymatic route for Sitagliptin key intermediate reduces costs and eliminates heavy metals. Ideal for reliable pharmaceutical intermediate suppliers seeking scalable API manufacturing solutions.
Patent CN1777572A reveals a robust ketone-based route for alkoxyphenols, offering superior stability and yield for reliable pharmaceutical intermediates supplier networks.
Patent CN114657164B reveals a novel enzymatic route for L-glufosinate, offering superior purity and cost efficiency for agrochemical intermediate supply chains.
Patent CN106916857B reveals a three-enzyme system for high-purity L-glufosinate-ammonium. This breakthrough enables significant cost reduction and supply chain reliability.
Patent CN118374468B reveals mutant transaminase for high yield chiral amine intermediate production with improved stereoselectivity.
Patent CN120718880B reveals high-efficiency transaminase mutant for Cinacalcet intermediate synthesis offering significant cost and supply chain advantages.
Patent CN114277073A reveals gene-knockout method for high-purity SAM. Reduces purification costs and ensures supply chain stability for pharmaceutical intermediates.
Novel enzymatic route for tofacitinib intermediate offers high purity and yield. Reduces cost and waste for pharmaceutical manufacturing supply chains.